VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects-Reference-Cited by-同舟云学术

VBP15, a novel anti‐inflammatory and membrane‐stabilizer, improves muscular dystrophy without side effects

Published:2013-09-09 Issue:10 Volume:5 Page:1569-1585
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Heier Christopher R.¹,Damsker Jesse M.²,Yu Qing¹,Dillingham Blythe C.¹²,Huynh Tony¹³,Van der Meulen Jack H.¹,Sali Arpana¹,Miller Brittany K.¹,Phadke Aditi¹,Scheffer Luana¹,Quinn James¹,Tatem Kathleen¹,Jordan Sarah¹,Dadgar Sherry¹⁴,Rodriguez Olga C.⁵⁶,Albanese Chris⁵⁶,Calhoun Michael⁷,Gordish‐Dressman Heather¹⁴,Jaiswal Jyoti K.¹⁴,Connor Edward M.¹²⁸,McCall John M.²⁹,Hoffman Eric P.¹²⁴,Reeves Erica K. M.²,Nagaraju Kanneboyina¹²⁴

Affiliation:

1. Center for Genetic Medicine ResearchChildren's National Medical CenterWashingtonDCUSA

2. ReveraGen BioPharmaRockvilleMDUSA

3. Endocrine Research UnitThe Canberra HospitalGarranACTAustralia

4. Department of Integrative Systems BiologyGeorge Washington University School of Medicine and Health SciencesWashingtonDCUSA

5. Lombardi Comprehensive Cancer Center and Department of OncologyGeorgetown University Medical CenterWashingtonDCUSA

6. Department of PathologyGeorgetown University Medical CenterWashingtonDCUSA

7. Sinq SystemsSilver SpringMDUSA

8. Center for Translational ScienceChildren's National Medical CenterWashingtonDCUSA

9. PharMac LLCBoca GrandeFLUSA

Publisher

EMBO